Summary of HRES 732 - Rare Cancer Day Resolution

Bill Overview

Bill Number: HRES 732

Title: Expressing support for the designation of September 30, 2025, as "Rare Cancer Day"

Status: Submitted in House

Introduced: September 17, 2025

Classification: Resolution

The resolution aims to raise awareness about rare cancers and the unique challenges faced by patients suffering from these conditions. By designating September 30, 2025, as "Rare Cancer Day," the bill seeks to foster greater understanding and support for early diagnosis and treatment options.

Main Purpose and Intent

The primary intent of HRES 732 is to:
- Highlight the difficulties in diagnosing rare cancers.
- Raise public awareness about the prevalence and impact of rare cancers.
- Encourage collaborative efforts to improve early detection and treatment.

Key Provisions

The resolution includes several important provisions:
1. Support for Rare Cancer Day: The House of Representatives expresses its support for the establishment of a designated day to focus on rare cancers.
2. Recognition of Challenges: Acknowledges the difficulties in detecting rare cancers and the significant impact they have on patients.
3. Awareness of Prevalence: Recognizes that rare cancers are a significant concern among cancer patients.
4. Survival Rates: Points out the lower survival rates associated with rare cancers compared to more common types of cancer.
5. Increased Awareness: Advocates for heightened awareness of rare cancer symptoms to facilitate early detection and improve survival outcomes.
6. Partnerships for Improvement: Encourages collaboration between medical and scientific communities to enhance early diagnosis and develop effective treatments.
7. Funding for Research: Supports the allocation of funding to explore potential cures and treatments for rare cancers.

Affected Parties

The resolution primarily affects:
- Patients with Rare Cancers: Individuals diagnosed with rare cancers who face unique challenges in treatment and diagnosis.
- Healthcare Providers: Medical professionals who will be encouraged to enhance their awareness and understanding of rare cancers.
- Research Institutions: Organizations involved in cancer research that may benefit from increased funding and collaboration opportunities.

Procedural Aspects

• Referral: The resolution was referred to the House Committee on Energy and Commerce on the same day it was introduced (September 17, 2025).
• Next Steps: The resolution will undergo further consideration and discussion within the committee before any potential voting or additional legislative action.

Conclusion

HRES 732 serves as an important step toward increasing awareness and support for individuals affected by rare cancers. By designating a specific day to focus on these issues, the resolution aims to foster a greater understanding of the challenges faced by patients and promote efforts to improve diagnosis and treatment options.